Karthickeyan Chella Krishnan1, Margarete Mehrabian1, Aldons J Lusis1,2,3. 1. Department of Medicine/Division of Cardiology. 2. Department of Microbiology, Immunology and Molecular Genetics. 3. Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Abstract
PURPOSE OF REVIEW: Sex differences are pervasive in metabolic and cardiovascular traits, yet they have often been ignored in human and animal model research. Sex differences can arise from reversible hormonal effects, from irreversible organizational (developmental) processes, and from gene expression differences from the X and Y chromosomes. We briefly review our current understanding of the impact of these factors in metabolic traits and disorders, with an emphasis on the recent literature. RECENT FINDINGS: Novel sex differences continue to be identified for metabolic and cardiovascular traits. For example, it is now clear that gut microbiota tend to differ between men and women, with potentially large implications for disease susceptibility. Also, tissue-specific gene regulation differs between men and women, contributing to differential metabolism. These new insights will open up personalized therapeutic avenues for cardiometabolic diseases. SUMMARY: Sex differences in body fat distribution, glucose homeostasis, insulin signaling, ectopic fat accumulation, and lipid metabolism during normal growth and in response to hormonal or nutritional imbalance are mediated partly through sex hormones and the sex chromosome complement. Most of these differences are mediated in a tissue-specific manner. Important future goals are to better understand the interactions between genetic variation and sex differences, and to bring an understanding of sex differences into clinical practice.
PURPOSE OF REVIEW: Sex differences are pervasive in metabolic and cardiovascular traits, yet they have often been ignored in human and animal model research. Sex differences can arise from reversible hormonal effects, from irreversible organizational (developmental) processes, and from gene expression differences from the X and Y chromosomes. We briefly review our current understanding of the impact of these factors in metabolic traits and disorders, with an emphasis on the recent literature. RECENT FINDINGS: Novel sex differences continue to be identified for metabolic and cardiovascular traits. For example, it is now clear that gut microbiota tend to differ between men and women, with potentially large implications for disease susceptibility. Also, tissue-specific gene regulation differs between men and women, contributing to differential metabolism. These new insights will open up personalized therapeutic avenues for cardiometabolic diseases. SUMMARY: Sex differences in body fat distribution, glucose homeostasis, insulin signaling, ectopic fat accumulation, and lipid metabolism during normal growth and in response to hormonal or nutritional imbalance are mediated partly through sex hormones and the sex chromosome complement. Most of these differences are mediated in a tissue-specific manner. Important future goals are to better understand the interactions between genetic variation and sex differences, and to bring an understanding of sex differences into clinical practice.
Authors: Olga Gealekman; Nina Guseva; Celia Hartigan; Sarah Apotheker; Matthew Gorgoglione; Kunal Gurav; Khan-Van Tran; Juerg Straubhaar; Sarah Nicoloro; Michael P Czech; Michael Thompson; Richard A Perugini; Silvia Corvera Journal: Circulation Date: 2011-01-03 Impact factor: 29.690
Authors: Marija Glisic; Blerim Mujaj; Oscar L Rueda-Ochoa; Eralda Asllanaj; Joop S E Laven; Maryam Kavousi; M Kamran Ikram; Meike W Vernooij; M Arfan Ikram; Oscar H Franco; Daniel Bos; Taulant Muka Journal: Circ Res Date: 2017-11-02 Impact factor: 17.367
Authors: Brian W Parks; Tamer Sallam; Margarete Mehrabian; Nikolas Psychogios; Simon T Hui; Frode Norheim; Lawrence W Castellani; Christoph D Rau; Calvin Pan; Jennifer Phun; Zhenqi Zhou; Wen-Pin Yang; Isaac Neuhaus; Peter S Gargalovic; Todd G Kirchgessner; Mark Graham; Richard Lee; Peter Tontonoz; Robert E Gerszten; Andrea L Hevener; Aldons J Lusis Journal: Cell Metab Date: 2015-02-03 Impact factor: 27.287
Authors: Ilan Gabriely; Xiao Hui Ma; Xiao Man Yang; Gil Atzmon; Michael W Rajala; Anders H Berg; Phillip Scherer; Luciano Rossetti; Nir Barzilai Journal: Diabetes Date: 2002-10 Impact factor: 9.461
Authors: Maarten J G Leening; Bart S Ferket; Ewout W Steyerberg; Maryam Kavousi; Jaap W Deckers; Daan Nieboer; Jan Heeringa; Marileen L P Portegies; Albert Hofman; M Arfan Ikram; M G Myriam Hunink; Oscar H Franco; Bruno H Stricker; Jacqueline C M Witteman; Jolien W Roos-Hesselink Journal: BMJ Date: 2014-11-17
Authors: Min Kim; Michael D Neinast; Aaron P Frank; Kai Sun; Jiyoung Park; Jordan A Zehr; Lavanya Vishvanath; Eugenia Morselli; Mason Amelotte; Biff F Palmer; Rana K Gupta; Philipp E Scherer; Deborah J Clegg Journal: Mol Metab Date: 2014-06-07 Impact factor: 7.422
Authors: Sanghee Park; Kristen D Turner; Donghai Zheng; Jeffrey J Brault; Kai Zou; Alec B Chaves; Thomas S Nielsen; Charles J Tanner; Jonas T Treebak; Joseph A Houmard Journal: J Physiol Date: 2018-12-02 Impact factor: 5.182
Authors: Stephanie E Hood; Xeniya V Kofler; Quiyu Chen; Judah Scott; Jason Ortega; Michael Lehmann Journal: J Lipid Res Date: 2020-09-28 Impact factor: 5.922
Authors: Jenna N McNeill; Emily S Lau; Emily K Zern; Matthew Nayor; Rajeev Malhotra; Elizabeth E Liu; Rohan R Bhat; Liana C Brooks; Robyn Farrell; John A Sbarbaro; Mark W Schoenike; Benjamin D Medoff; Gregory D Lewis; Jennifer E Ho Journal: Respir Med Date: 2021-04-30 Impact factor: 4.582
Authors: Florence E Davidson; Tandi E Matsha; Rajiv T Erasmus; Andre Pascal Kengne; Julia H Goedecke Journal: Cardiovasc J Afr Date: 2019-09-12 Impact factor: 1.167